Japanese innovative investment platform, Sanamedi, (previously JOMDD) specializes in investing and commercializing transformative new technologies in medical device development.

Established in 2012, with the mission of building an open innovation platform to provide an environment for the commercialization of healthcare innovations, Sanamedi provides a haven to incubate breakthrough advances in medical devices and consultative services for the development and commercialization of these cutting-edge products.

With sales channels already established in 23 markets and a solid track record of introducing medical devices to major hospitals around the world, Sanamedi has strong and proven capability to support Japanese medical device companies seeking global market access and distribution.

In early 2020, Jameel Health (Abdul Latif Jameel) and Sanamedi announced their investment/incubator partnership to bring innovative Japanese medical device technology to developing markets across the Global South.

Visit: Sanamedi